Kerendia was originally approved in July 2021 to reduce cardiovascular and kidney complications in patients with chronic ...

The startup is looking to not just cater to adults who know the importance of mental wellbeing in the modern age, but even ...

Sandra Currie OBE, chief executive of Peterborough based charity Kidney Research UK, has called for more focus on supporting those living with complex health conditions ...

The drug came to AstraZeneca through its acquisition of CinCor Pharma in 2023, with the hopes of beefing up its ...

The US regulator has cleared use of Kerendia (finerenone) for the treatment of heart failure patients who have a left ...

At two doses, baxdrostat demonstrated significant reduction in mean seated systolic BP vs. placebo at 12 weeks among patients with uncontrolled or treatment-resistant hypertension, AstraZeneca ...

The province has announced a $22 million investment over three years to modernize and expand the renal dialysis unit at the ...

Investigators conducted a qualitative study of Medicare Advantage expansion and marketing to patients with end-stage kidney disease (ESKD).

AHA comments on the U.S. Department of Health and Human Services request for information to ensure lawful regulation and unleash innovation to promote better health.

Investigators studied whether changes in renal hyperfiltration status affects patient outcomes using a Korean population cohort of more than 4.5 million patients.

Adherence to standard dialysis infection prevention and control (IPC) measures enabled safe provision of dialysis to patients ...